LRRK2-IN-1 is a compound that functions as an inhibitor of leucine-rich repeat kinase 2 (LRRK2), a protein kinase associated with Parkinson's disease. It is a pyrimidobenzodiazepine derivative with a complex structure containing multiple amine, amide, and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1234480-84-2
Siponimod fumarate
pharmaceutical raw material
Alpha/beta-Arteether
pharmaceutical raw material
Biperiden hydrochloride
pharmaceutical raw material
Azelnidipine
pharmaceutical raw material
2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one
IWMCPJZTADUIFX-UHFFFAOYSA-N
CN1CCN(CC1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C)OC